Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 13 tags : Phase 2b save search
Additional Data from Hepion Pharmaceuticals’ Phase 2a ‘AMBITION’ Trial Further Strengthens CRV431 Clinical Profile and Paves Way for Initiation of Phase 2b ‘ASCEND-NASH’ Clinical Program
Published: 2021-09-13 (Crawled : 19:00) - biospace.com/
HEPA | $1.47 4.26% 4.08% 71K
|
Health Technology
|
| O: 4.82%
H: 0.57%
C: -3.45%
phase 2 phase 2b nash trial crv431
Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe
Published: 2021-09-13 (Crawled : 13:00) - biospace.com/
MNPR | $0.631 -0.16% -0.32% 86K
|
Health Technology
|
| O: 2.34%
H: 2.28%
C: -9.67%
phase 2 europe phase 2b trial
BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough
Published: 2021-09-13 (Crawled : 12:00) - biospace.com/
BLU | $14.74 0.03% 0
|
Health Technology
|
| O: 20.66%
H: 8.88%
C: 1.06%
phase 2 positive chronic cough phase 2b trial blu-5937
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Announce Positive Data from a Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response of ATYR1923 in Pulmonary Sarcoidosis
Published: 2021-09-13 (Crawled : 12:00) - globenewswire.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 14.96%
H: 47.46%
C: 45.24%
biopharma phase 1 positive trial phase 1b phase 2b
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis
Published: 2021-09-13 (Crawled : 12:00) - globenewswire.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 14.96%
H: 47.46%
C: 45.24%
phase 1 positive trial phase 1b phase 2b response
Abstract for MIV-818 phase 1b monotherapy for ESMO Congress published
Published: 2021-09-13 (Crawled : 08:00) - prnewswire.com
IGMS | $7.73 14.52% 12.68% 410K
|
Health Technology
|
| O: 0.0%
H: 2.58%
C: -1.23%
phase 1 therapy phase 1b phase 2b
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.